Your browser doesn't support javascript.
loading
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
Willemsen, Annelieke E C A B; Grutters, Jan C; Gerritsen, Winald R; van Erp, Nielka P; van Herpen, Carla M L; Tol, Jolien.
Affiliation
  • Willemsen AE; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands.
  • Grutters JC; Department of Pulmonology, Centre of Interstitial Lung Diseases, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Gerritsen WR; Division of Heart & Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Erp NP; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands.
  • van Herpen CM; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Tol J; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands.
Int J Cancer ; 138(10): 2312-21, 2016 May 15.
Article in En | MEDLINE | ID: mdl-26452336

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Diseases, Interstitial / Protein Kinase Inhibitors / TOR Serine-Threonine Kinases / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2016 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Diseases, Interstitial / Protein Kinase Inhibitors / TOR Serine-Threonine Kinases / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2016 Type: Article Affiliation country: Netherlands